Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126286631 | 12628663 | 1 | I | 20160304 | 20160808 | 20160808 | PER | US-JAZZ-2016-US-004486 | JAZZ | 0.00 | M | Y | 0.00000 | 20160808 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126286631 | 12628663 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | 21196 | 3 | G | ORAL SOLUTION | |||||||
126286631 | 12628663 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3.75 G, BID | 21196 | 3.75 | G | ORAL SOLUTION | |||||||
126286631 | 12628663 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 4.5 G, BID | 21196 | 4.5 | G | ORAL SOLUTION | |||||||
126286631 | 12628663 | 4 | SS | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | 300 MG, UNK | 0 | 300 | MG | TABLET | ||||||||
126286631 | 12628663 | 5 | SS | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | 450 MG, UNK | 0 | 450 | MG | TABLET | ||||||||
126286631 | 12628663 | 6 | C | LIDODERM | LIDOCAINE | 1 | UNK | U | 0 | PATCH | |||||||||
126286631 | 12628663 | 7 | C | ADDERALL | AMPHETAMINE ASPARTATEAMPHETAMINE SULFATEDEXTROAMPHETAMINE SACCHARATEDEXTROAMPHETAMINE SULFATE | 1 | UNK | U | 0 | TABLET | |||||||||
126286631 | 12628663 | 8 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | UNK | U | 0 | TABLET | |||||||||
126286631 | 12628663 | 9 | C | ANDRODERM | TESTOSTERONE | 1 | UNK | U | 0 | PATCH | |||||||||
126286631 | 12628663 | 10 | C | CLONAZEPAM. | CLONAZEPAM | 1 | UNK | U | 0 | TABLET | |||||||||
126286631 | 12628663 | 11 | C | FINASTERIDE. | FINASTERIDE | 1 | UNK | U | 0 | TABLET | |||||||||
126286631 | 12628663 | 12 | C | TEMAZEPAM. | TEMAZEPAM | 1 | UNK | U | 0 | CAPSULE | |||||||||
126286631 | 12628663 | 13 | C | VITAMIN D | CHOLECALCIFEROL | 1 | UNK | U | 0 | ||||||||||
126286631 | 12628663 | 14 | C | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 1 | UNK | U | 0 | CAPSULE |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126286631 | 12628663 | 1 | Narcolepsy |
126286631 | 12628663 | 2 | Cataplexy |
126286631 | 12628663 | 4 | Depression |
126286631 | 12628663 | 6 | Product used for unknown indication |
126286631 | 12628663 | 7 | Product used for unknown indication |
126286631 | 12628663 | 8 | Product used for unknown indication |
126286631 | 12628663 | 9 | Product used for unknown indication |
126286631 | 12628663 | 10 | Product used for unknown indication |
126286631 | 12628663 | 11 | Product used for unknown indication |
126286631 | 12628663 | 12 | Product used for unknown indication |
126286631 | 12628663 | 13 | Product used for unknown indication |
126286631 | 12628663 | 14 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126286631 | 12628663 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126286631 | 12628663 | Depression | |
126286631 | 12628663 | Therapeutic response decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126286631 | 12628663 | 1 | 201206 | 2012 | 0 | |
126286631 | 12628663 | 2 | 201207 | 2015 | 0 | |
126286631 | 12628663 | 3 | 201503 | 0 | ||
126286631 | 12628663 | 6 | 20150806 | 20160101 | 0 | |
126286631 | 12628663 | 7 | 20140123 | 20151201 | 0 | |
126286631 | 12628663 | 8 | 20160101 | 0 | ||
126286631 | 12628663 | 12 | 20160101 | 0 |